Management ChangeJul 9, 2026, 07:36 AM
GSK Appoints Roy Jakobs as Non-Executive Director
AI Summary
GSK plc announced the appointment of Roy Jakobs as a Non-Executive Director to its Board, effective July 13, 2026. Mr. Jakobs, currently the Chief Executive Officer of Royal Philips, brings extensive experience in global health technology, which is expected to provide valuable perspective to GSK's focus on accelerating growth and delivering new medicines. The company highlighted his alignment with GSK's values and approach to culture and purpose.
Key Highlights
- Roy Jakobs appointed as Non-Executive Director of GSK plc.
- Appointment is effective from July 13, 2026.
- Mr. Jakobs currently serves as CEO of Royal Philips.
- He brings experience in global health technology and biopharmaceuticals.
- The Board determined Mr. Jakobs is an independent Non-Executive Director.
- He will receive an annual fee of £122,258.
- Required to build share ownership of GSK shares.
- GSK's Board will comprise 13 members as of July 13, 2026.
Price Impact
More from GSK